Hrt Financial LP Bridge Bio Pharma, Inc. Transaction History

Hrt Financial LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$27.35 - $40.45 $451,931 - $668,395	16,524 New	16,524 $510,000
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $628,493 - $1.3 Million	37,211 New	37,211 $981,000
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $407,040 - $1.05 Million	56,770 Added 53.74%	162,406 $2.69 Million
Q4 2022 Feb 10, 2023	BUY	$6.74 - $11.52 $70,689 - $120,821	10,488 Added 11.02%	105,636 $804,000
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $618,692 - $963,103	77,921 Added 452.32%	95,148 $945,000
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $89,752 - $209,135	17,227 New	17,227 $156,000
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $390,032 - $911,848	-53,138 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $2.18 Million - $10.2 Million	-191,518 Reduced 78.28%	53,138 $886,000
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $11.5 Million - $15.7 Million	244,656 New	244,656 $11.5 Million

290

170M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.31B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.